default author photo

Sanghee Lee

University of California, San Diego (UCSD) - Moores Cancer Center

1503, 3855 Health Sciences Dr.

La Jolla, CA 92093

United States

SCHOLARLY PAPERS

1

DOWNLOADS

41

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Basal-Luminal Hybrid Cells Emerge as a New Dormant, Androgen Pathway Directed Therapy-Resistant Population in Patient-Derived Prostate Cancer Organoids

Number of pages: 82 Posted: 29 Jul 2021
University of California, San Diego (UCSD) - Moores Cancer Center, University of California, San Diego (UCSD) - Moores Cancer Center, University of California, San Diego (UCSD) - Moores Cancer Center, University of California, San Diego (UCSD) - Moores Cancer Center, University of California, San Diego (UCSD) - Moores Cancer Center, University of California, San Diego (UCSD) - Moores Cancer Center, University of California, San Diego (UCSD) - Moores Cancer Center, University of California, San Diego (UCSD) - Moores Cancer Center, University of California, San Diego (UCSD) - Moores Cancer Center, University of California, San Diego (UCSD) - Department of Medicine, University of California, San Diego (UCSD) - Department of Medicine, University of California, Los Angeles (UCLA) - Department of Radiation Oncology, University of California, San Diego (UCSD) - Division of Regenerative Medicine, University of California, San Diego (UCSD) - Moores Cancer Center, Scripps MD Anderson Cancer Center, University of California, San Diego (UCSD) - Scripps Institute of Oceanograpy and University of California, San Diego (UCSD) - Moores Cancer Center
Downloads 41

Abstract:

Loading...

Androgen Pathway Directed Therapy (APDT), Angiotensin-Converting Enzyme 2 (ACE2), Basal-luminal hybrid, Bone Metastatic Prostate Cancer (BMPC), Dormant, Enzalutamide, Patient-derived Organoids (PDOs), Patient-Derived Xenograft (PDX), Prostate Cancer San Diego 1 (PCSD1), SARS-CoV-2